PP
AMPE

Paloma Partners’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Paloma Partners’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,468
Closed -$171K – 2389
2019
Q2 		$171K Buy
+1,468
New +$233K ﹤0.01% 1566
2017
Q3 		– Sell
-604
Closed -$94K – 2554
2017
Q2 		$94K Buy
+604
New +$122K ﹤0.01% 2080
2015
Q3 		– Sell
-194
Closed -$138K – 2028
2015
Q2 		$138K Buy
+194
New +$207K ﹤0.01% 1637

Other funds holding AMPE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return
CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return
TW
Transform Wealth Greenwood Village, Colorado $1.65B AUM 19.1% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Paloma Partners's AMPE Position: Q3 2019 in Review

Paloma Partners sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q3 2019, closing a stake of 1,468 shares — an estimated $171K sold.

Paloma Partners first reported a position in AMPE in Q2 2015 and held it in 3 quarters. The position peaked at $171K in Q2 2019. 75 funds tracked by Wall St. Rank hold AMPE as of Q3 2019.

  • Paloma Partners reported no remaining Ampio Pharmaceuticals Inc. position as of Q3 2019 after selling out during the quarter.
  • Paloma Partners sold 1,468 Ampio Pharmaceuticals Inc. shares in Q3 2019, an estimated $171K.
  • Paloma Partners first reported a position in Ampio Pharmaceuticals Inc. in Q2 2015 and held it in 3 quarters.
  • Paloma Partners's Ampio Pharmaceuticals Inc. position peaked at $171K in Q2 2019.
  • 75 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q3 2019.

Based on Paloma Partners's 13F filing for Q3 2019, filed 14 Nov 2019.